Orea-Soufi, A., Castillo-Lluva, S., Salvador-Tormo, N., Martín-Cabrera, P., Recuero, S., Gabicagogeascoa, E., . . . Lorente, M. (2021). The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer. MDPI AG.
Style de citation Chicago (17e éd.)Orea-Soufi, Alba, et al. The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer. MDPI AG, 2021.
Style de citation MLA (8e éd.)Orea-Soufi, Alba, et al. The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer. MDPI AG, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.